Neomaxx Pharmaceuticals Private Limited - Board Members
Founded in 2019 and headquartered in Karnataka, India.
2019 Hubli, Karnataka (India) Active
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Basalingappa Channabasappa Navadgi Appointed as Director since January 2022 | Director | 30-Jan-2022 | Current |
Bramhavar Shamburao Ramesh Appointed as Director since March 2020 | Director | 21-Mar-2020 | Current |
Drsuresh Yeshwanth Patil Appointed as Director since September 2019 | Director | 20-Sep-2019 | Current |
Narasimhan Raju Appointed as Director since March 2020 | Director | 21-Mar-2020 | Current |
Prashant Shivappa Holkunde Appointed as Director since September 2019 | Director | 20-Sep-2019 | Current |
Sharanabasappa Kamreddy Appointed as Director since March 2020 | Director | 21-Mar-2020 | Current |
Vishnu Prabhu Appointed as Director since March 2020 | Director | 21-Mar-2020 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Neomaxx Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Neomaxx Pharmaceuticals Private Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Neomaxx Pharmaceuticals Private Limited through their registered address at Shivalingamma Heerad Memorial Complex, 3 Floor 3 Cross, Hosur, Hubli Karnataka, 580021, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Neomaxx Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- DRSURESH YESHWANTH PATIL
- NARASIMHAN RAJU
- BRAMHAVAR SHAMBURAO RAMESH
- VISHNU PRABHU
- SHARANABASAPPA KAMREDDY
- PRASHANT SHIVAPPA HOLKUNDE
- BASALINGAPPA CHANNABASAPPA NAVADGI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.